glp 1 drug made by eli lilly FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Lilly is selling $12.9 billion
Description
Acknowledgements A.C., F.P
Where Phase 3 Stands Phase 3 trials are currently underway as of April 2026, evaluating retatrutide across larger, more diverse populations and longer timeframes

Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset
Reduced success with fertility treatments : Obesity is associated with lower pregnancy rates and higher miscarriage rates in women undergoing assisted reproductive technologies

This degradation is catalyzed by the ubiquitous serum enzyme dipeptidyl peptidase 4 (DPP-4), which is produced both locally in the intestine and by circulating white blood cells
doi: 10.1016/j.bbr.2017.11.015 [DOI] [PubMed] [Google Scholar] 119.Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodrguez M, et al
